Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 5/20 | 0.37 |
| ▸ | PDE4A | P27815 | 4/20 | 0.37 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.37 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17286312 | 0.86 | PDE4B (0.38) | PDE4BPDE4APDE4CPDE4DTNFRSF1A | |
| SCHEMBL15700813 | 0.85 | PDE4B (0.35) | PDE4BPDE4APDE4CPDE4DTNFRSF1A | |
| SCHEMBL14645969 | 0.85 | PDE4B (0.37) | PDE4BPDE4APDE4CPDE4DTNFRSF1A | |
| SCHEMBL17409131 | 0.85 | — | — | |
| SCHEMBL28110282 | 0.84 | PDE4B (0.35) | PDE4BPDE4APDE4CPDE4DTNFRSF1A | |
| Hydrochloric Acid SCHEMBL22653349 | 0.84 | PDE4B (0.36) | PDE4BPDE4APDE4CPDE4DTNFRSF1A | |
| Hydrochloric Acid SCHEMBL16286923 | 0.84 | PDE4B (0.36) | PDE4BPDE4APDE4CPDE4DTNFRSF1A | |
| SCHEMBL3736095 | 0.83 | PDE4B (0.35) | PDE4BPDE4APDE4CPDE4DTNFRSF1A | |
| Hydrochloric Acid SCHEMBL27905100 | 0.83 | PDE4B (0.35) | PDE4BPDE4APDE4CPDE4DTNFRSF1A | |
| SCHEMBL17783835 | 0.82 | PDE4B (0.35) | PDE4BPDE4APDE4CPDE4DTNFRSF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9469699-B2 | Catalysts | BOREALIS AG (AT) | 2016-10-18 | — | — | US | disclosed |
| US-20160002369-A1 | CATALYSTS | BOREALIS AG (AT) | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002369-A1 | CATALYSTS | SIGMAR1, SFN, AP3S1 | PDE4B 4863/4885PDE4A 4877/4885PDE4C 4864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.